From particle count to residence time: a kinetic framework for atherogenic risk. [PDF]
Larronde E.
europepmc +1 more source
Cardiovascular events in individuals with small/medium LDL particle discordance
Schmidt AF +9 more
europepmc +1 more source
Cholesteryl ester transfer protein inhibition with obicetrapib is associated with attenuated decline in kidney function in patients at high cardiovascular risk: Post hoc pooled results from the BROADWAY and BROOKLYN trials. [PDF]
Vogt L +10 more
europepmc +1 more source
Efficacy and safety of obicetrapib in patients at high cardiovascular risk: a systematic review, meta-analysis, and meta-regression. [PDF]
Kumar S +16 more
europepmc +1 more source
Tridax procumbens promotes apoptosis and suppresses markers of proliferation, growth, and metastasis in pancreatic ductal adenocarcinoma cells. [PDF]
Samuel E +3 more
europepmc +1 more source
Fusion Protein Technology to Enhance Pharmacological Properties of L-Asparaginases. [PDF]
Shishparenok AN, Blinova VG, Zhdanov DD.
europepmc +1 more source
Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. [PDF]
Inia JA +13 more
europepmc +1 more source
RT-ICI therapy induces a distal immunometabolic axis that shapes systemic macrophage polarization and enhances local T cell immunity. [PDF]
Ge Y +6 more
europepmc +1 more source
Pathway-Based Genetic Risk Scores Are Associated with Blood Lipids Among Young Mexican Adults. [PDF]
Hannon Esteves BA +5 more
europepmc +1 more source

